Incyte told JP Morgan attendees of plans for four launches in 2025, beginning with its FDA-approved Niktimvo for chronic GVHD.

May River Capital, a Chicago-based lower middle-market private equity firm, today announced the merger of its portfolio companies, Advanced Material Processing ('AMP') and Automated Handling Solutions ...